The observed upregulation of Chrm2 and Trpv2 detected in the bladder following VCR treatment seems to be aligned with this notion as these genes have been described to play a role in bladder contractility and overactive bladder pathology50–52. The gene discussed is CHRM2; the disease is overactive bladder.